In addition to hematological malignancies, lower frequencies of SF3B1 mutation are also found in solid tumors such as breast cancers (1.8%), pancreatic carcinoma (4%), uveal melanoma (9.7%), and endometrial cancers (percentages not reported) [9]. Here, SF3B1 is linked to breast cancer.